ARENA PHARMACEUTICALS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 7589
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 69186
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 20186
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1237
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 11127
 
  
 
C07K PEPTIDES 11125
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 8159
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 693
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5120

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0360,730 MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETOMar 02, 17Dec 21, 17[A61K, C07D, C07C]
2017/0304,327 CANNABINOID RECEPTOR MODULATORSFeb 08, 17Oct 26, 17[A61K]
2017/0239,263 METHOD OF WEIGHT MANAGEMENTOct 06, 16Aug 24, 17[A61K, G09B, A23L, A61B, A63B]
2017/0217,885 SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSNov 09, 16Aug 03, 17[C07D]
2017/0143,704 CANNABINOID RECEPTOR MODULATORSSep 29, 16May 25, 17[A61K]
2016/0304,463 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETOApr 25, 16Oct 20, 16[C07D]
2016/0009,654 CRYSTALLINE FORMS OF (R)-8-CHLORO-1-METHYL- 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE HYDROCHLORIDEMar 02, 15Jan 14, 16[C07D]
2014/0051,629 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETOSep 21, 11Feb 20, 14[A61K, C07D]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9867822 Cannabinoid receptor modulatorsSep 29, 16Jan 16, 18[A61K, C07F, C07D]
9801856 serotonin receptor modulator useful for the treatment of disorders related theretoApr 06, 15Oct 31, 17[A61K, C07D]
9783502 serotonin receptorOct 23, 15Oct 10, 17[C07D]
9775829 Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related theretoFeb 02, 16Oct 03, 17[A61K, C07D]
9770455 Administration of an anti-obesity compound to individuals with renal impairmentJan 05, 17Sep 26, 17[A61K]
9745270 Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related theretoMay 02, 16Aug 29, 17[A61K, C07D]
9732039 Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related theretoApr 22, 15Aug 15, 17[C07D]
9676758 1-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related theretoApr 29, 16Jun 13, 17[C07D]
9663500 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related theretoMar 16, 15May 30, 17[C07D]
9597340 Cannabinoid receptor modulatorsFeb 24, 12Mar 21, 17[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0096,398 NON-HYGROSCOPIC SALTS OF 5-HT2C AGONISTSAbandonedMay 10, 16Apr 06, 17[A61K, C07D, C07C]
2016/0250,223 5HT2C RECEPTOR MODULATORSAbandonedMay 12, 16Sep 01, 16[A61K]
2016/0185,729 PROCESSES FOR PREPARING 3-BENZAZEPINESAbandonedJul 27, 15Jun 30, 16[C07D, C07C]
2016/0151,381 SALTS OF LORCASERIN WITH OPTICALLY ACTIVE ACIDSAbandonedJul 29, 15Jun 02, 16[A61K]
2016/0077,113 Methods of Identifying Candidate Compounds of the Human G Protein-Coupled Receptor, GPR50, as Modulators of Body Mass or AdiposityAbandonedMay 21, 15Mar 17, 16[A61K, G01N, C07K]
2016/0024,014 5HT2C RECEPTOR MODULATORSAbandonedFeb 23, 15Jan 28, 16[C07D]
2015/0336,966 SUBSTITUTED TRICYCLIC ACID DERIVATIVES AS S1P1 RECEPTOR AGONISTS USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSAbandonedAug 04, 15Nov 26, 15[C07D]
2015/0297,610 METHOD OF WEIGHT MANAGEMENTAbandonedNov 06, 12Oct 22, 15[A61K]
2015/0284,399 PROCESSES FOR THE PREPARATION OF S1P1 RECEPTOR MODULATORS AND CRYSTALLINE FORMS THEREOFAbandonedJun 15, 15Oct 08, 15[C07D]
2015/0265,576 PRIMARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETOAbandonedFeb 27, 15Sep 24, 15[A61K]
2015/0210,625 PROCESSES FOR THE PREPARATION OF 5-HT2C RECEPTOR AGONISTSAbandonedDec 23, 14Jul 30, 15[C07C]
2015/0196,567 ADMINISTRATION OF AN ANTI-OBESITY COMPOUND TO INDIVIDUALS WITH RENAL IMPAIRMENTAbandonedMar 27, 15Jul 16, 15[A61K, G01N]
2015/0191,454 MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETOAbandonedDec 10, 14Jul 09, 15[C07D]
2015/0174,102 ETHERS, SECONDARY AMINES AND DERIVATIVES THEREOF AS MODULATORS OF THE 5-HT 2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETOAbandonedFeb 27, 15Jun 25, 15[A61K]
2015/0153,327 Endogenous and Non-Endogenous Versions of Human G Protein-Coupled ReceptorsAbandonedJun 24, 14Jun 04, 15[G01N, C07K]
2015/0126,527 MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETOAbandonedOct 09, 14May 07, 15[A61K]
2015/0087,634 5HT2C RECEPTOR MODULATOR COMPOSITIONSAbandonedApr 23, 14Mar 26, 15[A61K]
2015/0038,701 PROCESSES FOR THE PREPARATION OF 8-CHLORO-1-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE AND INTERMEDIATES RELATED THERETOAbandonedJul 01, 14Feb 05, 15[C07D]
2014/0309,192 MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETOAbandonedNov 07, 12Oct 16, 14[C07F, C07D]
2014/0255,310 Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Atherosclerosis and Atherosclerotic Disease and for the Treatment of Conditions Related to MCP-1 ExpressionAbandonedFeb 13, 14Sep 11, 14[A61K, G01N, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.